Product Code: ETC7539187 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Carbapenem Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Carbapenem Market Revenues & Volume, 2021 & 2031F |
3.3 India Carbapenem Market - Industry Life Cycle |
3.4 India Carbapenem Market - Porter's Five Forces |
3.5 India Carbapenem Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 India Carbapenem Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 India Carbapenem Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Carbapenem Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of multidrug-resistant bacterial infections in India |
4.2.2 Rising awareness about the importance of appropriate antibiotic use |
4.2.3 Growth in healthcare infrastructure and expenditure in the country |
4.3 Market Restraints |
4.3.1 High cost associated with carbapenem antibiotics |
4.3.2 Regulatory challenges and stringent approval processes |
4.3.3 Potential side effects and risks associated with carbapenem usage |
5 India Carbapenem Market Trends |
6 India Carbapenem Market, By Types |
6.1 India Carbapenem Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 India Carbapenem Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 India Carbapenem Market Revenues & Volume, By Meropenem, 2021- 2031F |
6.1.4 India Carbapenem Market Revenues & Volume, By Imipenem, 2021- 2031F |
6.1.5 India Carbapenem Market Revenues & Volume, By Ertapenem, 2021- 2031F |
6.2 India Carbapenem Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 India Carbapenem Market Revenues & Volume, By Urinary Tract Infections, 2021- 2031F |
6.2.3 India Carbapenem Market Revenues & Volume, By Bloodstream Infections, 2021- 2031F |
6.2.4 India Carbapenem Market Revenues & Volume, By Intra-abdominal Infections, 2021- 2031F |
6.2.5 India Carbapenem Market Revenues & Volume, By Pneumonia, 2021- 2031F |
6.3 India Carbapenem Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 India Carbapenem Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 India Carbapenem Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
7 India Carbapenem Market Import-Export Trade Statistics |
7.1 India Carbapenem Market Export to Major Countries |
7.2 India Carbapenem Market Imports from Major Countries |
8 India Carbapenem Market Key Performance Indicators |
8.1 Rate of prescription of carbapenem antibiotics by healthcare providers |
8.2 Number of reported cases of carbapenem-resistant infections |
8.3 Investments in research and development for new carbapenem formulations |
8.4 Adoption rate of guidelines promoting judicious use of carbapenems in healthcare facilities |
8.5 Patient outcomes and recovery rates associated with carbapenem treatment |
9 India Carbapenem Market - Opportunity Assessment |
9.1 India Carbapenem Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 India Carbapenem Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 India Carbapenem Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Carbapenem Market - Competitive Landscape |
10.1 India Carbapenem Market Revenue Share, By Companies, 2024 |
10.2 India Carbapenem Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |